Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S SHERRY

Showing results (41-50 of 121) with videos related to

Pageof 13
Sort By:
Angiology|January 1, 1982
Clinical management of the thrombosed vessel: an overviewS Sherry
The American Journal of Cardiology|April 15, 1987
Recombinant tissue plasminogen activator (rt-PA): is it the thrombolytic agent of choice for an evolving acute myocardial infarction?S Sherry
Hospital Practice (Office Ed.)|November 1, 1990
Bleeding complications in thrombolytic therapyS Sherry
The New England Journal of Medicine|June 10, 1971
Thrombosis preventionS Sherry
Transactions of the Association of American Physicians|January 1, 1975
William Smith Tillett. 1892-1974S Sherry
Advances in Prostaglandin, Thromboxane, and Leukotriene Research|January 1, 1982
Effect of prostaglandin-mediated platelet-suppressant drugs on acute cardiovascular catastrophesS Sherry
Cardiovascular Clinics|January 1, 1983
Role of platelet-active drugs in coronary artery diseaseS Sherry
Circulation|December 1, 1980
The anturane reinfarction trialS Sherry
Thrombosis Et Diathesis Haemorrhagica|February 28, 1973
Clinical trials with antithrombotic and thrombolytic agents. Principles and pitfallsS Sherry
Thrombosis and Haemostasis|February 28, 1979
The Anturane reinfarction trialS Sherry
Pageof 13

Showing results (41-50 of 121) with videos related to

Sort By:
Pageof 13
Angiology|January 1, 1982
Clinical management of the thrombosed vessel: an overviewS Sherry
The American Journal of Cardiology|April 15, 1987
Recombinant tissue plasminogen activator (rt-PA): is it the thrombolytic agent of choice for an evolving acute myocardial infarction?S Sherry
Hospital Practice (Office Ed.)|November 1, 1990
Bleeding complications in thrombolytic therapyS Sherry
The New England Journal of Medicine|June 10, 1971
Thrombosis preventionS Sherry
Transactions of the Association of American Physicians|January 1, 1975
William Smith Tillett. 1892-1974S Sherry
Advances in Prostaglandin, Thromboxane, and Leukotriene Research|January 1, 1982
Effect of prostaglandin-mediated platelet-suppressant drugs on acute cardiovascular catastrophesS Sherry
Cardiovascular Clinics|January 1, 1983
Role of platelet-active drugs in coronary artery diseaseS Sherry
Circulation|December 1, 1980
The anturane reinfarction trialS Sherry
Thrombosis Et Diathesis Haemorrhagica|February 28, 1973
Clinical trials with antithrombotic and thrombolytic agents. Principles and pitfallsS Sherry
Thrombosis and Haemostasis|February 28, 1979
The Anturane reinfarction trialS Sherry
Pageof 13